title: [MODIFIED INTRAVESICAL CHEMOTHERAPY OF BLADDER CANCER].
abstract: This paper gives an account of an experimental and clinical application of super-low frequency scanning magnetic field in patients with noninvasive bladder cancer treated with adjuvant intravesical gemcitabine chemotherapy. Treatment of isolated bladder cancer cells incubated with gemcitabine by this physical factor increased the permeability of cell membranes to the chemotherapy drug. This effect was demonstrated by increased fluorescence intensity of cancer cells. Clinical application of this combination therapy technology showed 2,8-fold increase of disease-free survival interval compared to early recurrences in the control group. These results indicate the potential of biophysical mechanisms to increase chemotherapy effectiveness.
authors.forename: A N
authors.initials: AN
authors.lastname: Shevchenko
authors.forename: A I
authors.initials: AI
authors.lastname: Shihjarova
authors.forename: E V
authors.initials: EV
authors.lastname: Filatova
authors.forename: O V
authors.initials: OV
authors.lastname: Tarnopol'skaja
authors.forename: T A
authors.initials: TA
authors.lastname: Kurkina
authors.forename: S G
authors.initials: SG
authors.lastname: Seleznev
authors.forename: I A
authors.initials: IA
authors.lastname: Homutenko
authors.forename: D A
authors.initials: DA
authors.lastname: Shvyrev
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D055909:Magnetic Field Therapy / Q000379:methods*; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine